OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A brief history of antidepressant drug development: from tricyclics to beyond ketamine
Vitor Silva Pereira, Vinicius Sato
Acta Neuropsychiatrica (2018) Vol. 30, Iss. 6, pp. 307-322
Open Access | Times Cited: 97
Vitor Silva Pereira, Vinicius Sato
Acta Neuropsychiatrica (2018) Vol. 30, Iss. 6, pp. 307-322
Open Access | Times Cited: 97
Showing 1-25 of 97 citing articles:
Neuroinflammation and depression: A review
Romain Troubat, Pascal Barone, Samuel Leman, et al.
European Journal of Neuroscience (2020) Vol. 53, Iss. 1, pp. 151-171
Closed Access | Times Cited: 731
Romain Troubat, Pascal Barone, Samuel Leman, et al.
European Journal of Neuroscience (2020) Vol. 53, Iss. 1, pp. 151-171
Closed Access | Times Cited: 731
Antidepressant Medications and Weight Change: A Narrative Review
Hartej Gill, Barjot Gill, Sabine El‐Halabi, et al.
Obesity (2020) Vol. 28, Iss. 11, pp. 2064-2072
Open Access | Times Cited: 123
Hartej Gill, Barjot Gill, Sabine El‐Halabi, et al.
Obesity (2020) Vol. 28, Iss. 11, pp. 2064-2072
Open Access | Times Cited: 123
Major depressive disorder: Validated treatments and future challenges
Rabie Karrouri, Zakaria Hammani, Roukaya Benjelloun, et al.
World Journal of Clinical Cases (2021) Vol. 9, Iss. 31, pp. 9350-9367
Open Access | Times Cited: 101
Rabie Karrouri, Zakaria Hammani, Roukaya Benjelloun, et al.
World Journal of Clinical Cases (2021) Vol. 9, Iss. 31, pp. 9350-9367
Open Access | Times Cited: 101
Antidepressants promote the spread of antibiotic resistance via horizontally conjugative gene transfer
Pengbo Ding, Ji Lu, Yue Wang, et al.
Environmental Microbiology (2022) Vol. 24, Iss. 11, pp. 5261-5276
Open Access | Times Cited: 50
Pengbo Ding, Ji Lu, Yue Wang, et al.
Environmental Microbiology (2022) Vol. 24, Iss. 11, pp. 5261-5276
Open Access | Times Cited: 50
Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants
Wenwen Duan, Dongmei Cao, Sheng Wang, et al.
Chemical Reviews (2023) Vol. 124, Iss. 1, pp. 124-163
Closed Access | Times Cited: 30
Wenwen Duan, Dongmei Cao, Sheng Wang, et al.
Chemical Reviews (2023) Vol. 124, Iss. 1, pp. 124-163
Closed Access | Times Cited: 30
A Microbial-Based Approach to Mental Health: The Potential of Probiotics in the Treatment of Depression
Dinyadarshini Johnson, Vengadesh Letchumanan, C. Thum, et al.
Nutrients (2023) Vol. 15, Iss. 6, pp. 1382-1382
Open Access | Times Cited: 28
Dinyadarshini Johnson, Vengadesh Letchumanan, C. Thum, et al.
Nutrients (2023) Vol. 15, Iss. 6, pp. 1382-1382
Open Access | Times Cited: 28
Anti-inflammatory properties of commonly used psychiatric drugs
Shrujna Patel, Brooke A. Keating, Russell C. Dale
Frontiers in Neuroscience (2023) Vol. 16
Open Access | Times Cited: 23
Shrujna Patel, Brooke A. Keating, Russell C. Dale
Frontiers in Neuroscience (2023) Vol. 16
Open Access | Times Cited: 23
THERAPEUTIC MECHANISMS OF KETAMINE
Slobodan Mihaljević, Matko Pavlović, Kresimir Reine, et al.
Psychiatria Danubina (2020) Vol. 32, Iss. 3-4, pp. 325-333
Open Access | Times Cited: 51
Slobodan Mihaljević, Matko Pavlović, Kresimir Reine, et al.
Psychiatria Danubina (2020) Vol. 32, Iss. 3-4, pp. 325-333
Open Access | Times Cited: 51
Rapid-acting antidepressants and the circadian clock
Shogo Sato, Blynn G. Bunney, Lucía Mendoza-Viveros, et al.
Neuropsychopharmacology (2021) Vol. 47, Iss. 4, pp. 805-816
Open Access | Times Cited: 45
Shogo Sato, Blynn G. Bunney, Lucía Mendoza-Viveros, et al.
Neuropsychopharmacology (2021) Vol. 47, Iss. 4, pp. 805-816
Open Access | Times Cited: 45
The Economics of Treatment for Depression
Chad Stecher, Sara Cloonan, Marisa Elena Domino
Annual Review of Public Health (2023) Vol. 45, Iss. 1, pp. 527-551
Closed Access | Times Cited: 17
Chad Stecher, Sara Cloonan, Marisa Elena Domino
Annual Review of Public Health (2023) Vol. 45, Iss. 1, pp. 527-551
Closed Access | Times Cited: 17
Role of Serotonylation and SERT Posttranslational Modifications in Alzheimer's Disease Pathogenesis
Arubala P. Reddy, Priyanka Rawat, Nicholas Rohr, et al.
Aging and Disease (2024)
Open Access | Times Cited: 5
Arubala P. Reddy, Priyanka Rawat, Nicholas Rohr, et al.
Aging and Disease (2024)
Open Access | Times Cited: 5
Effectiveness of Ketamine for the Treatment of Post-Traumatic Stress Disorder - A Systematic Review and Meta-Analysis.
Thales Marcon Almeida, Ursula Raianny Lacerda da Silva, Jeully Pereira Pires, et al.
PubMed (2024) Vol. 21, Iss. 1, pp. 22-31
Closed Access | Times Cited: 5
Thales Marcon Almeida, Ursula Raianny Lacerda da Silva, Jeully Pereira Pires, et al.
PubMed (2024) Vol. 21, Iss. 1, pp. 22-31
Closed Access | Times Cited: 5
Antioxidant Potential of Psychotropic Drugs: From Clinical Evidence to In Vitro and In Vivo Assessment and toward a New Challenge for in Silico Molecular Design
Giovanni Ribaudo, Marco Bortoli, Chiara Pavan, et al.
Antioxidants (2020) Vol. 9, Iss. 8, pp. 714-714
Open Access | Times Cited: 40
Giovanni Ribaudo, Marco Bortoli, Chiara Pavan, et al.
Antioxidants (2020) Vol. 9, Iss. 8, pp. 714-714
Open Access | Times Cited: 40
Neuropharmacology of Organoselenium Compounds in Mental Disorders and Degenerative Diseases
Paloma T. Birmann, Angela Maria Casaril, Laura Abenante, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 21, pp. 2357-2395
Closed Access | Times Cited: 23
Paloma T. Birmann, Angela Maria Casaril, Laura Abenante, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 21, pp. 2357-2395
Closed Access | Times Cited: 23
A Study on the Preventive Effect of Esketamine on Postpartum Depression (PPD) after Cesarean Section
Qiwei Wang, Maoxin Xiao, Hao Sun, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-5
Open Access | Times Cited: 22
Qiwei Wang, Maoxin Xiao, Hao Sun, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-5
Open Access | Times Cited: 22
Why Are Some People with Lower Urinary Tract Symptoms (LUTS) Depressed? New Evidence That Peripheral Inflammation in the Bladder Causes Central Inflammation and Mood Disorders
Francis M. Hughes, Michael R. Odom, Anissa Cervantes, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2821-2821
Open Access | Times Cited: 15
Francis M. Hughes, Michael R. Odom, Anissa Cervantes, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2821-2821
Open Access | Times Cited: 15
New trends in personalized treatment of depression
Gaia Sampogna, Claudia Toni, Pierluigi Catapano, et al.
Current Opinion in Psychiatry (2023) Vol. 37, Iss. 1, pp. 3-8
Closed Access | Times Cited: 15
Gaia Sampogna, Claudia Toni, Pierluigi Catapano, et al.
Current Opinion in Psychiatry (2023) Vol. 37, Iss. 1, pp. 3-8
Closed Access | Times Cited: 15
Unraveling the Role of the Blood-Brain Barrier in the Pathophysiology of Depression: Recent Advances and Future Perspectives
Shamili Mariya Varghese, Shashikant Patel, Amritasree Nandan, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 12, pp. 10398-10447
Closed Access | Times Cited: 5
Shamili Mariya Varghese, Shashikant Patel, Amritasree Nandan, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 12, pp. 10398-10447
Closed Access | Times Cited: 5
Safety in treatment: Classical pharmacotherapeutics and new avenues for addressing maternal depression and anxiety during pregnancy
Merel Dagher, Catherine M. Cahill, Anne M. Andrews
Pharmacological Reviews (2025) Vol. 77, Iss. 3, pp. 100046-100046
Closed Access
Merel Dagher, Catherine M. Cahill, Anne M. Andrews
Pharmacological Reviews (2025) Vol. 77, Iss. 3, pp. 100046-100046
Closed Access
Rapid and sustained antidepressant effects of tubastatin A in a mouse model of depression
Masahide Fukada, Yoshiharu Kawaguchi, Atsuo Nakayama
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Masahide Fukada, Yoshiharu Kawaguchi, Atsuo Nakayama
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Connecting the dots: Understanding and addressing the metabolic impact of antipsychotic and antidepressant medications
Susanne U. Miedlich, J. Steven Lamberti
Annals of the New York Academy of Sciences (2025)
Closed Access
Susanne U. Miedlich, J. Steven Lamberti
Annals of the New York Academy of Sciences (2025)
Closed Access
The Selective SIK2 Inhibitor ARN-3236 Produces Strong Antidepressant-Like Efficacy in Mice via the Hippocampal CRTC1-CREB-BDNF Pathway
Yue Liu, Wenqian Tang, Chun-Hui Ji, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 30
Yue Liu, Wenqian Tang, Chun-Hui Ji, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 30
Antidepressants as Endocrine Disrupting Compounds in Fish
William A. Thompson, Mathilakath M. Vijayan
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 20
William A. Thompson, Mathilakath M. Vijayan
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 20
The role of GPR39 zinc receptor in the modulation of glutamatergic and GABAergic transmission
Gabriela Starowicz, Dominika Siodłak, Gabriel Nowak, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 3, pp. 609-622
Open Access | Times Cited: 12
Gabriela Starowicz, Dominika Siodłak, Gabriel Nowak, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 3, pp. 609-622
Open Access | Times Cited: 12
The emergence of antidepressant drugs targeting GABAA receptors: A concise review
Xénia Gonda, Frank I. Tarazi, Péter Döme
Biochemical Pharmacology (2024) Vol. 228, pp. 116481-116481
Open Access | Times Cited: 4
Xénia Gonda, Frank I. Tarazi, Péter Döme
Biochemical Pharmacology (2024) Vol. 228, pp. 116481-116481
Open Access | Times Cited: 4
